NCT00606749View on ClinicalTrials.gov

Use of KC706 for the Treatment of Pemphigus Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Pemphigus Vulgaris
Interventions
DRUG

KC706

300 mg once daily (QD) for 12 weeks.

Trial Locations (1)

19104

Victoria Werth, MD, Philadelphia

All Listed Sponsors
lead

Kemia, Inc

INDUSTRY

NCT00606749 - Use of KC706 for the Treatment of Pemphigus Vulgaris | Biotech Hunter | Biotech Hunter